• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝细胞癌中Wnt信号抑制剂DACT2的表观遗传调控

Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.

作者信息

Zhang Xiaomei, Yang Yunsheng, Liu Xuefeng, Herman James G, Brock Malcolm V, Licchesi Julien D F, Yue Wen, Pei Xuetao, Guo Mingzhou

机构信息

Department of Gastroenterology & Hepatology; Chinese PLA General Hospital; Beijing, P.R. China.

The Sidney Kimmel Comprehensive Cancer Institute at Johns Hopkins; Johns Hopkins University; Baltimore, MD USA.

出版信息

Epigenetics. 2013 Apr;8(4):373-82. doi: 10.4161/epi.24113. Epub 2013 Feb 28.

DOI:10.4161/epi.24113
PMID:23449122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3674046/
Abstract

DACT2 (Dapper, Dishevelled-associated antagonist of β-catenin homolog 2) is a member of the DACT family involved in the regulation of embryonic development. Human DACT2 is localized on 6q27, a region of frequent loss of heterozygosity in human cancers. However, the regulation of DACT2 expression and function in hepatocellular carcinoma (HCC) remains unclear. In this study, genetic and epigenetic changes of DACT2 were analyzed in HCC cell lines and primary cancer. We found no single-nucleotide polymorphism (SNP) associated with HCC. Promoter region methylation was correlated with loss or reduction of DACT2 expression, and restoration of DACT2 expression was induced by 5-aza-2'-deoxycytidine (5-AZA) in HCC cell lines. Promoter region methylation was found in 54.84% of primary HCC. Reduction of DACT2 expression was associated with promoter hypermethylation, and expression of DACT2 was inversely related to β-catenin expression in primary HCC. DACT2 suppressed cell proliferation, induced G 2-M arrest in cell lines and inhibited tumor growth in xenograft nude mice. The transcriptional activity of TCF-4 and the expression of Wnt signaling downstream genes were suppressed by DACT2 re-expression and reactivated by depletion of DACT2. In conclusion, DACT2 is frequently methylated in HCC and its expression is regulated by promoter hypermethylation. DACT2 suppresses HCC by inhibiting Wnt signaling in human HCC.

摘要

DACT2(β-连环蛋白同源物2的Dapper、紊乱相关拮抗剂)是参与胚胎发育调控的DACT家族成员。人类DACT2定位于6q27,该区域在人类癌症中经常出现杂合性缺失。然而,DACT2在肝细胞癌(HCC)中的表达和功能调控仍不清楚。在本研究中,分析了HCC细胞系和原发性癌中DACT2的遗传和表观遗传变化。我们未发现与HCC相关的单核苷酸多态性(SNP)。启动子区域甲基化与DACT2表达的缺失或降低相关,并且在HCC细胞系中,5-氮杂-2'-脱氧胞苷(5-AZA)可诱导DACT2表达的恢复。在54.84%的原发性HCC中发现了启动子区域甲基化。DACT2表达的降低与启动子高甲基化相关,并且在原发性HCC中,DACT2的表达与β-连环蛋白的表达呈负相关。DACT2抑制细胞增殖,在细胞系中诱导G2-M期阻滞,并抑制异种移植裸鼠中的肿瘤生长。DACT2的重新表达可抑制TCF-4的转录活性以及Wnt信号下游基因的表达,而DACT2的缺失则可使其重新激活。总之,DACT2在HCC中经常发生甲基化,其表达受启动子高甲基化调控。DACT2通过抑制人类HCC中的Wnt信号来抑制HCC。

相似文献

1
Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.人肝细胞癌中Wnt信号抑制剂DACT2的表观遗传调控
Epigenetics. 2013 Apr;8(4):373-82. doi: 10.4161/epi.24113. Epub 2013 Feb 28.
2
Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.人类肺癌中 Wnt 信号通路关键组分 DACT2 的表观遗传调控。
J Pathol. 2013 Jun;230(2):194-204. doi: 10.1002/path.4073.
3
DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.DACT2是一种通过抑制Wnt/β-连环蛋白信号通路发挥作用的肿瘤抑制因子,与结肠癌患者的不良预后相关。
Oncogene. 2015 May 14;34(20):2575-85. doi: 10.1038/onc.2014.201. Epub 2014 Jul 14.
4
Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.DACT2的甲基化通过激活Wnt信号通路促进甲状腺乳头状癌转移。
PLoS One. 2014 Nov 6;9(11):e112336. doi: 10.1371/journal.pone.0112336. eCollection 2014.
5
DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.启动子CpG甲基化导致的DACT2沉默破坏了其对乳腺癌细胞上皮-间质转化和细胞骨架重组的调控。
Oncotarget. 2016 Oct 25;7(43):70924-70935. doi: 10.18632/oncotarget.12341.
6
The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.新的 6q27 肿瘤抑制因子 DACT2 常因 CpG 甲基化而失活,通过 β-连环蛋白/Cdc25c 信号通路和 G2/M 期阻滞使鼻咽癌细胞对紫杉醇和 5-FU 的毒性敏感。
Clin Epigenetics. 2018 Feb 27;10(1):26. doi: 10.1186/s13148-018-0459-2.
7
Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.DACT2的甲基化通过激活Wnt信号通路加速食管癌的发展。
Oncotarget. 2016 Apr 5;7(14):17957-69. doi: 10.18632/oncotarget.7647.
8
Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.DACT2 的甲基化通过激活 Wnt 信号通路促进乳腺癌的发展。
Sci Rep. 2017 Jun 12;7(1):3325. doi: 10.1038/s41598-017-03647-3.
9
Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing.DACT2 表达降低促进肝细胞癌进展:涉及甲基化介导的基因沉默。
World J Surg Oncol. 2013 Mar 7;11:57. doi: 10.1186/1477-7819-11-57.
10
SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.SOX1 通过拮抗肝细胞癌中的 WNT/β-连环蛋白信号通路发挥肿瘤抑制作用。
Hepatology. 2012 Dec;56(6):2277-87. doi: 10.1002/hep.25933.

引用本文的文献

1
Vitamin D receptor prevents tumour development by regulating the Wnt/β-catenin signalling pathway in human colorectal cancer.维生素 D 受体通过调节人结直肠癌中的 Wnt/β-连环蛋白信号通路来预防肿瘤发生。
BMC Cancer. 2023 Apr 12;23(1):336. doi: 10.1186/s12885-023-10690-z.
2
The Role of DACT Family Members in Tumorigenesis and Tumor Progression.DACT 家族成员在肿瘤发生和肿瘤进展中的作用。
Int J Biol Sci. 2022 Jul 11;18(11):4532-4544. doi: 10.7150/ijbs.70784. eCollection 2022.
3
HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC.HCV 核心蛋白通过表观遗传沉默抑制 DKK3 的表达,并在 HCC 进展过程中激活 Wnt/β-catenin 信号通路。
Clin Transl Oncol. 2022 Oct;24(10):1998-2009. doi: 10.1007/s12094-022-02859-y. Epub 2022 Jun 29.
4
Rhenium Treatment Induces Expression in Hepatocellular Carcinoma Cells.铼治疗可诱导肝癌细胞中的表达。
Cell J. 2022 May;24(5):215-221. doi: 10.22074/cellj.2022.7894. Epub 2022 Apr 27.
5
The Role of MiR-181 Family Members in Endothelial Cell Dysfunction and Tumor Angiogenesis.miR-181 家族成员在血管内皮细胞功能障碍和肿瘤血管生成中的作用。
Cells. 2022 May 18;11(10):1670. doi: 10.3390/cells11101670.
6
DACT2 regulates structural and electrical atrial remodeling in atrial fibrillation.DACT2调节心房颤动中的心房结构和电重构。
J Thorac Dis. 2020 May;12(5):2039-2048. doi: 10.21037/jtd-19-4206.
7
Dact3 inhibits the malignant phenotype of non-small cell lung cancer through downregulation of c-Myb.Dact3通过下调c-Myb抑制非小细胞肺癌的恶性表型。
Int J Clin Exp Pathol. 2017 Dec 1;10(12):11580-11587. eCollection 2017.
8
Investigating the methylation status of gene and its association with C677T polymorphism in patients with colorectal cancer.研究结直肠癌患者中基因的甲基化状态及其与C677T多态性的关联。
Mol Biol Res Commun. 2019 Jun;8(2):53-58. doi: 10.22099/mbrc.2019.33006.1393.
9
MicroRNA-214 promotes the proliferation, migration and invasion of gastric cancer MKN28 cells by suppressing the expression of Dact2.微小RNA-214通过抑制Dact2的表达促进胃癌MKN28细胞的增殖、迁移和侵袭。
Exp Ther Med. 2018 Dec;16(6):4909-4917. doi: 10.3892/etm.2018.6771. Epub 2018 Sep 19.
10
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.TMEM176A 的表观遗传沉默激活人肝细胞癌中的 ERK 信号通路。
Clin Epigenetics. 2018 Nov 6;10(1):137. doi: 10.1186/s13148-018-0570-4.

本文引用的文献

1
Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.人类肺癌中 Wnt 信号通路关键组分 DACT2 的表观遗传调控。
J Pathol. 2013 Jun;230(2):194-204. doi: 10.1002/path.4073.
2
Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.肝细胞癌发生和静脉转移中 microRNA 表达的顺序改变。
Hepatology. 2012 May;55(5):1453-61. doi: 10.1002/hep.25512.
3
Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention?miR-224 在肝细胞癌中的作用:一种可能的治疗干预工具?
Epigenomics. 2011 Apr;3(2):235-43. doi: 10.2217/epi.11.5.
4
Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC).单核苷酸多态性(5p15.33、15q25.1、6p22.1、6q27 和 7p15.3)与欧洲癌症前瞻性调查与营养研究(EPIC)中的肺癌生存。
Mutagenesis. 2011 Sep;26(5):657-66. doi: 10.1093/mutage/ger030. Epub 2011 Jul 12.
5
All Dact (Dapper/Frodo) scaffold proteins dimerize and exhibit conserved interactions with Vangl, Dvl, and serine/threonine kinases.所有 Dact(Dapper/Frodo)支架蛋白都会二聚化,并与 Vangl、Dvl 和丝氨酸/苏氨酸激酶表现出保守的相互作用。
BMC Biochem. 2011 Jun 30;12:33. doi: 10.1186/1471-2091-12-33.
6
Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.配对盒基因 5 通过与 p53 信号通路相互作用成为肝癌的一种新型肿瘤抑制因子。
Hepatology. 2011 Mar;53(3):843-53. doi: 10.1002/hep.24124. Epub 2011 Feb 11.
7
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
8
The value of epigenetic markers in esophageal cancer.表观遗传标记物在食管癌中的价值。
Front Med China. 2010 Dec;4(4):378-84. doi: 10.1007/s11684-010-0230-3. Epub 2010 Nov 24.
9
SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.SOX17 在肝癌中拮抗 WNT/β-catenin 信号通路。
Epigenetics. 2010 Nov-Dec;5(8):743-9. doi: 10.4161/epi.5.8.13104. Epub 2010 Nov 22.
10
Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatment in HER2-negative or unknown metastatic breast cancer.在一项将拉帕替尼或安慰剂与紫杉醇联合用于HER2阴性或未知的转移性乳腺癌一线治疗的随机试验中,雌激素受体、孕激素受体、人表皮生长因子受体2(HER2)和表皮生长因子受体的表达以及从拉帕替尼治疗中获得的益处。
J Clin Oncol. 2009 Aug 20;27(24):3908-15. doi: 10.1200/JCO.2008.18.1925. Epub 2009 Jul 20.